Search

everythinglearnresearchcommunity

for

Search:↓

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Premature balding in some men may be linked to altered hormones, but it's not the male equivalent to polycystic ovary syndrome or metabolic syndrome.

A very-low-calorie diet led to more weight loss and health improvements in obese women with PCOS than a moderate energy deficit diet.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

The study concluded that androstendione and DHEA are important for diagnosing high male hormone levels in women with excessive hair growth.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

About 19.4% of Iranian women in the study have Polycystic Ovary Syndrome, with the most common type involving irregular periods and high male hormone levels, but their heart and metabolic health is similar to women without the condition.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

Probiotic supplements may help reduce inflammation and oxidative stress in women with PCOS.

The link between physical signs of high male hormones and hormone levels in women with PCOS changes with age.

Combined oral contraceptives improve skin, hormone levels, and quality of life in women with PCOS.

Women with PCOS and polycystic ovaries have higher male hormone levels and more insulin resistance, especially if they are overweight.

Women with excessive body hair often have higher male hormones and related health issues.

High DHEA and short cervical length in women with PCOS and recurrent miscarriages may harm pregnancy outcomes.

Higher testosterone and DHEA-S levels may be linked to male pattern baldness.

Insulin resistance is strongly linked to higher androgen levels in women with PCOS.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

Women with PCOS often have sleep problems, including sleep apnea, which are linked to obesity and depression.

Women with PCOS have higher levels of certain androgens, which are good at predicting excess hair growth.

Both finasteride and drospirenone effectively manage PCOS symptoms, but drospirenone is more effective in reducing ovarian volume and androgen levels.

Obese women with PCOS are more likely to have fatty liver disease.

MPA improved hormonal imbalances and acne in women with PCOS without affecting metabolism.